Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets close in 43 mins

S&P 500
5,853.78
-0.20(-0.00%)
Dow 30
42,978.81
+47.21(+0.11%)
Nasdaq
18,575.06
+35.05(+0.19%)
Russell 2000
2,231.90
-7.81(-0.35%)
Crude Oil
72.24
+1.68(+2.38%)
Gold
2,759.20
+20.30(+0.74%)

Amphastar Pharmaceuticals, Inc. (AMPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

50.85

+0.03

(+0.06%)

As of 03:16PM EDT. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	2.49B
Enterprise Value	2.89B
Trailing P/E	16.13
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	3.78
Price/Book (mrq)	3.49
Enterprise Value/Revenue	4.06
Enterprise Value/EBITDA	9.67

Trading Information

Stock Price History

Beta (5Y Monthly)	0.83
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	65.92
52 Week Low ³	36.56
50-Day Moving Average ³	47.31
200-Day Moving Average ³	45.52

Share Statistics

Avg Vol (3 month) ³	354.96k
Avg Vol (10 day) ³	276.97k
Shares Outstanding ⁵	48.96M
Implied Shares Outstanding ⁶	N/A
Float ⁸	37.69M
% Held by Insiders ¹	22.33%
% Held by Institutions ¹	72.01%
Shares Short (Sep 30, 2024) ⁴	4.35M
Short Ratio (Sep 30, 2024) ⁴	12.03
Short % of Float (Sep 30, 2024) ⁴	13.53%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	8.89%
Shares Short (prior month Aug 30, 2024) ⁴	4.21M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	23.36%
Operating Margin (ttm)	30.27%

Management Effectiveness

Return on Assets (ttm)	10.13%
Return on Equity (ttm)	25.57%

Income Statement

Revenue (ttm)	712.89M
Revenue Per Share (ttm)	14.72
Quarterly Revenue Growth (yoy)	25.20%
Gross Profit (ttm)	N/A
EBITDA	284.16M
Net Income Avi to Common (ttm)	166.52M
Diluted EPS (ttm)	3.15
Quarterly Earnings Growth (yoy)	45.30%

Balance Sheet

Total Cash (mrq)	217.78M
Total Cash Per Share (mrq)	4.47
Total Debt (mrq)	620.58M
Total Debt/Equity (mrq)	87.00
Current Ratio (mrq)	3.52
Book Value Per Share (mrq)	14.57

Cash Flow Statement

Operating Cash Flow (ttm)	212.6M
Levered Free Cash Flow (ttm)	35.29M